PUB - Publikationen an der Universität Bielefeld

Alle markieren

• [9]
  

  2024 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2987695

  Krug D, Vladimirova V, Untch M, et al. Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapy. Breast . 2024;74.

  PUB | DOI | PubMed | Europe PMC
   
• [8]
  

  2024 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987540

  Herold N, Schmolling J, Ernst C, et al. Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer. In: Abstracts from the 56th European Society of Human Genetics (ESHG) Conference. European Journal of Human Genetics . Vol 32. London: Nature; 2024: 548.

  PUB | WoS
   
• [7]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2979534

  Imterat M, Harter P, Rhiem K, et al. Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma Patients. Cancers. 2023;15(9): 2534.

  PUB | PDF | DOI | WoS | PubMed | Europe PMC
   
• [6]
  

  2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2985382

  Slomovitz BM, Raaschou-Jensen N, Coleman RL, et al. PFS2 and adjustment of overall survival (OS) for subsequent anticancer therapy in patients (pts) with primary advanced or recurrent endometrial cancer (pA/rEC) treated with dostarlimab plus chemotherapy or chemotherapy alone in the ENGOT-EN3-NSGO/GOG-3031/RUBY trial. In: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023. Annals of Oncology . Vol 34. Amsterdam: Elsevier; 2023: S514-S515.

  PUB | DOI | WoS
   
• [5]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2984317

  Marme F, Krieghoff-Henning E, Gerber B, et al. Deep learning to predict breast cancer sentinel lymph node status on INSEMA histological images. European Journal of Cancer. 2023;195: 113390.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [4]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2984002

  Imterat M, Gebers G, Heitz F, et al. Low anterior resection syndrome and its impact on quality of life of ovarian carcinoma patients: A prospective longitudinal study. Gynecologic Oncology. 2023;178:96-101.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [3]
  

  2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2984318

  Bizzarri N, Imterat M, Fruscio R, et al. Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth? European Journal of Cancer. 2023;195: 113398.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [2]
  

  2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2980959

  Herold N, Schmolling J, Ernst C, et al. Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer. Cancer Medicine . 2023.

  PUB | DOI | WoS | PubMed | Europe PMC
   
• [1]
  

  2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2979540

  Inci MG, Sehouli J, Schnura E, et al. The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial design. International Journal of Gynecological Cancer . 2023: ijgc-2023-004531.

  PUB | DOI | WoS | PubMed | Europe PMC